Efficacy of satralizumab as monotherapy in pre-specified subgroups of SAkuraStar, a double-blind placebo-controlled phase 3 clinical study in patients with neuromyelitis optica spectrum disorder (NMOSD)
2019 ◽
Vol 405
◽
pp. 172
◽
2019 ◽
Vol 405
◽
pp. 171
◽
2019 ◽
Vol 405
◽
pp. 11-12
◽
2020 ◽
Vol 19
(5)
◽
pp. 402-412
◽
2020 ◽
Vol 37
◽
pp. 101592
◽